Background
Methods
Participants
Angiographic morphology of coronary stenosis
Anthropometry and laboratory tests
Statistical analysis
Results
Non-CAD group | Single-vessel group | p value (Non-CAD group versus Single-vessel group) | Multi-vessels group | p value (Non-CAD group versus Multi-vessels group) | p value (Single-vessel group versus Multi-vessels group) | |
---|---|---|---|---|---|---|
Number | 15 | 22 | 16 | |||
Age, years | 65 ± 2 | 65 ± 2 | 0.910 | 66 ± 2 | 0.889 | 0.817 |
Body mass index, kg/m2 | 25.0 ± 0.9 | 23.8 ± 0.7 | 0.666 | 25.6 ± 1.0 | 0.359 | 0.135 |
Visceral fat area, cm2 | 111 ± 14 | 121 ± 14 | 0.205 | 123 ± 14 | 0.255 | 0.898 |
Subcutaneous fat area, cm2 | 137 ± 18 | 138 ± 12 | 0.341 | 141 ± 11 | 0.394 | 0.918 |
Smoking (none-/ex-/current-smoker), n | 8/5/2 | 9/5/8 | 0.566 | 3/4/9 | 0.149 | 0.230 |
Diabetes mellitus, n | 9 | 11 | 0.644 | 9 | 0.879 | 0.793 |
Sulfonyl ureas/glinides/biguanides/alpha glucosidase inhibitors/Insulin, n | 5/0/1/1/2 | 7/5/6/1/2 | 4/0/1/4/2 | |||
Hypertension, n | 13 | 16 | 0.436 | 11 | 0.392 | 0.886 |
Calcium channel antagonists/angiotensin receptor blockers/β-blockers/diuretics, n | 8/2/2/0 | 13/12/4/2 | 6/8/6/2 | |||
Dyslipidemia, n | 7 | 14 | 0.430 | 10 | 0.525 | 0.965 |
Statins/fibrates/ezetimibe/cholestimide, n | 5/1/0/0 | 10/0/1/1 | 9/1/0/0 | |||
Anti-platelet drugs (aspirin/ticlopidine/clopidogrel), n | 4/0/2 | 22/0/22 | 16/6/10 | |||
Family history of CAD, n | 2 | 2 | 0.753 | 5 | 0.392 | 0.116 |
Systolic blood pressure, mmHg | 134 ± 4 | 137 ± 4 | 0.808 | 139 ± 5 | 0.981 | 0.802 |
Diastolic blood pressure, mmHg | 78 ± 2 | 74 ± 2 | 0.135 | 77 ± 3 | 0.586 | 0.407 |
Hemoglobin A1c (NGSP),% | 6.9 ± 0.5 | 6.4 ± 0.2 | 0.255 | 6.6 ± 0.4 | 0.661 | 0.519 |
LDL-C, mg/dL | 123 ± 6 | 110 ± 7 | 0.193 | 113 ± 9 | 0.789 | 0.132 |
Triglyceride, mg/dL | 124 ± 16 | 152 ± 19 | 0.290 | 125 ± 12 | 0.969 | 0.273 |
HDL-C, mg/dL | 61 ± 4 | 57 ± 4 | 0.352 | 48 ± 3 | 0.005* | 0.139 |
Creatinine, mg/dL | 0.82 ± 0.04 | 0.87 ± 0.06 | 0.880 | 0.82 ± 0.02 | 0.475 | 0.510 |
Target lesions (LMCA/LAD/LCX/RCA), n | - | 0/20/1/1 | 1/40/13/2 | |||
ACC/AHA (Type A/B/C) | - | 6/12/4 | 5/7/4 | |||
Procedures (PCI/CABG), n | - | 22/0 | 15/1 |